MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation

Nature Genetics

Volumn 29, Issue 3, 2001, Pages 287-294

  Trockenbacher, Alexander ^a   Suckow, Vanessa ^b   Foerster, John ^c   Winter, Jennifer ^b   Krauß, Sybille ^b   Ropers, Hans Hilger ^b   Schneider, Rainer ^a   Schweiger, Susann ^b  

^a Biocenter Innsbruck Fritz   (Austria)

^b MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LIGASE; MICROTUBULE ASSOCIATED PROTEIN; PHOSPHOPROTEIN PHOSPHATASE 2A; UBIQUITIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME PHOSPHORYLATION; FETUS; GENE MUTATION; HUMAN; HUMAN CELL; OPITZ SYNDROME; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; BINDING SITES; BLOTTING, WESTERN; COS CELLS; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LIGASES; MICROTUBULE PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; MICROTUBULES; MODELS, BIOLOGICAL; MUTATION; NUCLEAR PROTEINS; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; POLYUBIQUITIN; PRECIPITIN TESTS; PROTEIN BINDING; PROTEIN SUBUNITS; SUBSTRATE SPECIFICITY; SYNDROME; TRANSCRIPTION FACTORS; TWO-HYBRID SYSTEM TECHNIQUES; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES; UP-REGULATION;

EID: 0035184651     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng762     Document Type: Article

References (48)

1. Opitz G/BBB syndrome: Clinical comparisons of families linked to Xp22 and 22q, a review of the literature
2. Opitz syndrome is genetically heterogenous, with one locus on Xp22, and a second locus on 22q11.2
3. Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22
4. The Opitz syndrome gene product, MID1, associates with microtubules
5. Identification of a RING protein that can interact in vivo with the 8RCA1 gene product
6. In vivo and in vitro characterization of the B1 and B2 zinc-binding domains from the acute promyelocytic leukemia protooncoprotein PML
7. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein
8. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53
9. Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3-kinase for ubiquitination in T cells
10. Ubiquitination of a new form of α-synuclein by parkin from human brain: Implications for Parkinson's disease
11. Proteolysis and the cell cycle: With this RING I do thee destroy
12. B cell receptor-associated protein α4 displays rapamycin sensitive binding directly to the catalytic subunit of protein phosphatase 2A
13. An anchoring factor targets protein phosphatase 2A to brain microtubules
14. Mechanistic studies on the inactivation of the proteasome by lactacystin
15. α4 associates with protein phosphatase 2A, 4, and 6
16. Molecular cloning of a cDNA clone encoding a phosphoprotein component related to the Ig receptor-mediated signal transduction
17. MID2. A homologue of the Opitz syndrome gene MID1: Similarities in subcellular localization and differences in expression during development
18. The tripartite motif family identifies cell compartments
19. The ubiquitin-conjugating enzymes UbcH7 and UbcH8 interact with RING finger/IBR motif-containing domains of HHARI and H7-AP1
20. Functional characterization of the Opitz syndrome gene product (midin): Evidence for homodimerization and association with microtubules throughout the cell cycle
21. A novel pool of protein phosphatase 2A is associated with microtubules and is regulated during the cell cycle
22. Autoregulation of protein phosphatase type 2A expression
23. Type 2A protein phosphatase, the complex regulator of numerous signaling pathways
24. Serine/threonine protein phosphatases
25. Protein phosphatase 2A: Who shall regulate the regulator?
26. Phosphorylation of paired helical filament tau in Alzheimer's disease neurofibrillary lesions: Focusing on phosphatases
27. Reduction of Ha-ras-induced cellular transformation by elevated expression of protein phosphatase type 2A
28. 2/M cell-cycle checkpoint
29. Identification of a domain of axin that binds to the serine/threonine protein phosphatase 2A and a self-binding domain
30. Mutation of twins encoding a regulator of protein phosphatase 2A leads to pattern duplication in Drosophila imaginal disks
31. Reversible phosphorylation of bcl2 following interleukin 3 or bryostatin 1 is mediated by direct interaction with protein phosphatase 2A
32. Regulation of protein phosphatase 2A activity by caspase-3 during apoptosis
33. Regulation of cytoskeletal organization in tumor cells by protein phosphatase-1 and -2A
34. Truncated isoform of the PP2A B56 subunit promotes cell motility through paxillin phosphorylation
35. Process formation of podocytes: Morphogenetic activity of microtubules and regulation by protein serine/threonine phosphatase PP2A
36. Regulation of phosphorylation of neuronal microtubule-associated proteins MAP1b and MAP2 by protein phosphatase-2A and -2B in rat brain
37. Regulation of microtubule dynamics by microtubule-associated protein expression and phosphorylation during neuronal development
38. LIS1 is a microtubule-associated phosphoprotein
39. Phosphorylation and microtubule association of the Opitz syndrome protein mid-1 is regulated by protein phosphatase 2A via binding to the regulatory subunit α 4
40. The lore of the RiNGs: Substrate recognition and catalysis by ubiquitin ligases
41. RING for destruction?
42. RING finger proteins: Mediators of ubiquitin ligase activity
43. Regulation of protein phosphatase 2A catalytic activity by α 4 protein and its yeast homologue Tap42
44. A gene for FG syndrome maps in the Xq12-q 21.31 region
45. Report of three new families with linkage to Xq12-q 22.1
46. The FG syndrome: An X-linked recessive syndrome of multiple congenital anomalies and mental retardation
47. The two-hybrid system: An assay for protein-protein interactions
48. Two-dimensional electrophoresis of proteins: An updated protocol and implications for a functional analysis of the genome